YOU ARE HERE:
HIV & AIDS Treatment in Practice #2, 27 March 2003
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings. It is supported by and produced in collaboration with St Stephen's AIDS Trust and the International HIV/AIDS Alliance.
Its publication is also supported by Positive Action of GlaxoSmithKline, Boehringer Ingelheim and the Access 4 Trust.
Its publication is also supported by Positive Action of GlaxoSmithKline, Boehringer Ingelheim and the Access 4 Trust.
IN THIS ISSUE
About HIV & AIDS Treatment in Practice
News links from www.aidsmap.com
Nevirapine-based fixed-dose combination ARVs (main feature)
NEWS LINKS FROM WWW.AIDSMAP.COM
A selection of news stories which have appeared since 13 March 2003.
'Inspirational' Nkosi Johnson honoured by London HIV clinic
clinic at the West London Centre for Sexual Health was relaunched as the
Nkosi Johnson unit.
Adherence the factor most associated with HIV suppression in semen
detectable in the semen of men taking anti-HIV drugs in a Brazilian study
published in the April 2003 edition of the Journal of Acquired Immune
Deficiency Syndromes.
Investment funds tell drug companies to improve treatment access for
poorest countries
management are calling on pharmaceutical companies to take swift steps to
ensure that poor countries have access to essential medicines.
Is a liver biopsy really needed in an HIV/HCV patient?
for people coinfected with HIV and hepatitis C (HCV) may be unnecessary in
the majority of cases as tests on biochemical markers can, in most cases,
give an indication of liver damage according to two recent studies.
Pakistani and Afghani drug users at high HIV risk
knowledge of HIV and the risk factors that lead to infection, according to
a study conducted by the Johns Hopkins Bloomberg School of Public Health.
The researchers found that only 16 percent of the study participants were
aware of the existence of HIV or AIDS.
Testing and conselling increases condom use in HIV-discordant couples, but unsafe sex under-reported
increase in self-reported condom use amongst HIV-discordant heterosexual
couples in a study conducted by the University of Alabama and University
of Zambia in Lusaka, Zambia. However, the study, which is published in the
28th March 2003 edition of AIDS, also showed that biological markers were
able to detect widespread under-reporting of unprotected sex.
Women do just as well as men on HAART, major cohort reports
EuroSIDA cohort published in the 1st April 2003 edition of the Journal of
Acquired Immune Deficiency Syndromes (now available online).
South African HIV treatment activists start civil disobedience programme
disobedience tactics employed by the governing ANC to bring down the
apartheid regime to highlight the refusal of the ruling party to provide
anti-HIV drugs.
AIDS in Africa: WHO & UNAIDS reaffirm unsafe sex as main mode of
transmission
Joint United Nations Programme on HIV/AIDS (UNAIDS) hosted an expert
consultation which addressed issues related to unsafe injection practices
and HIV in healthcare contexts and evaluated the relative contribution of
unsafe injections to HIV transmission in sub-Saharan Africa.
Alcohol increases SIV 64-fold in monkeys: implications for HIV transmission
HIV main infectious cause of death amongst pregnant South African women
South Africa, according to a report recently released by the country's
health ministry.
About HIV & AIDS Treatment in Practice
News links from www.aidsmap.com
Nevirapine-based fixed-dose combination ARVs (main feature)
NEWS LINKS FROM WWW.AIDSMAP.COM
A selection of news stories which have appeared since 13 March 2003.
'Inspirational' Nkosi Johnson honoured by London HIV clinic
- At a special naming and dedication ceremony held this morning the HIV
clinic at the West London Centre for Sexual Health was relaunched as the
Nkosi Johnson unit.
Adherence the factor most associated with HIV suppression in semen
- Poor adherence was the single factor most likely to result in HIV being
detectable in the semen of men taking anti-HIV drugs in a Brazilian study
published in the April 2003 edition of the Journal of Acquired Immune
Deficiency Syndromes.
Investment funds tell drug companies to improve treatment access for
poorest countries
- A coalition of UK and European investment funds with $943 billion under
management are calling on pharmaceutical companies to take swift steps to
ensure that poor countries have access to essential medicines.
Is a liver biopsy really needed in an HIV/HCV patient?
- Liver biopsies, the "gold standard" for reaching treatment decisions
for people coinfected with HIV and hepatitis C (HCV) may be unnecessary in
the majority of cases as tests on biochemical markers can, in most cases,
give an indication of liver damage according to two recent studies.
Pakistani and Afghani drug users at high HIV risk
- The majority of Pakistani and Afghani male drug injectors lack basic
knowledge of HIV and the risk factors that lead to infection, according to
a study conducted by the Johns Hopkins Bloomberg School of Public Health.
The researchers found that only 16 percent of the study participants were
aware of the existence of HIV or AIDS.
Testing and conselling increases condom use in HIV-discordant couples, but unsafe sex under-reported
- Voluntary HIV testing and counselling was associated with a substantial
increase in self-reported condom use amongst HIV-discordant heterosexual
couples in a study conducted by the University of Alabama and University
of Zambia in Lusaka, Zambia. However, the study, which is published in the
28th March 2003 edition of AIDS, also showed that biological markers were
able to detect widespread under-reporting of unprotected sex.
Women do just as well as men on HAART, major cohort reports
- Men and women do equally well on HAART according to data from the
EuroSIDA cohort published in the 1st April 2003 edition of the Journal of
Acquired Immune Deficiency Syndromes (now available online).
South African HIV treatment activists start civil disobedience programme
- HIV treatment activists in South Africa are using the civil
disobedience tactics employed by the governing ANC to bring down the
apartheid regime to highlight the refusal of the ruling party to provide
anti-HIV drugs.
AIDS in Africa: WHO & UNAIDS reaffirm unsafe sex as main mode of
transmission
- Last Friday (14th March) the World Health Organisation (WHO) and the
Joint United Nations Programme on HIV/AIDS (UNAIDS) hosted an expert
consultation which addressed issues related to unsafe injection practices
and HIV in healthcare contexts and evaluated the relative contribution of
unsafe injections to HIV transmission in sub-Saharan Africa.
Alcohol increases SIV 64-fold in monkeys: implications for HIV transmission
HIV main infectious cause of death amongst pregnant South African women
- HIV is the leading infectious cause of death amongst pregnant women in
South Africa, according to a report recently released by the country's
health ministry.
aidsmap resources
Africa news
- Promising early results for large-scale study of community-level HIV prevention initiative
- Children starting HIV treatment in sub-Saharan Africa have a low risk of death
- Different paediatric responses to antiretroviral therapy in Uganda and the United Kingdom/Ireland may reflect differences in nutrition and access to cotrimoxazole
Asia and Pacific news
- CD4 cell count increases sustained up to five years in developing-world treatment programmes
- Reduced dose atazanavir safe and effective in small Thai study
- Switching to AZT from d4T poses challenges in resource-limited settings
Eastern Europe and Russia news
- HIV diagnoses in European MSM have almost doubled since 2000, UK tops the list
- Long hospital stays for TB treatment can increase risk of reinfection with MDR or XDR-TB strains
- Long hospital stays for TB treatment can increase risk of reinfection with MDR or XDR-TB strains
Latin America news
- CD4 cell count increases sustained up to five years in developing-world treatment programmes
- Brazil rejects tenofovir patent
- Immigration and prevention: the effect of migration on risk behaviour
Middle East news
- Justice Edwin Cameron calls for a campaign against 'misguided criminal laws and prosecutions'
- Half of all new HIV infections could be averted if proven prevention efforts expanded
- Roche agrees to temporary suspension of nelfinavir's (Viracept) European license - updated
Treatment access news
- HIV testing for mothers and children must expand, UN report shows
- Universal testing and treatment could reduce new HIV infections in southern Africa by 95% in 10 years
- Migrants with MDR-TB in southern Africa being dumped off at borders without referrals to care
